Cognitive progression independent of relapse activity in different multiple sclerosis phenotypes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Cognitive progression independent of relapse activity in different multiple sclerosis phenotypes ; volume:82 ; number:S 01 ; year:2024 ; 01
Konferenz: 25th BCTRIMS Annual Meeting; 2024-06-05; Tivoli Mofarrej São Paulo - SP
Arquivos de neuro-psiquiatria ; 82, Heft S 01 (2024), 01
- Contributor
-
de Negreiros, Andre Augusto Lemos Vidal
Gois, Larissa
de Sá, Mariana
Vieira, Gabriel
Damasceno, Alfredo
- DOI
-
10.1055/s-0044-1789321
- URN
-
urn:nbn:de:101:1-2412121008238.465407719138
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- de Negreiros, Andre Augusto Lemos Vidal
- Gois, Larissa
- de Sá, Mariana
- Vieira, Gabriel
- Damasceno, Alfredo
Other Objects (12)
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study
Seasonal variation in multiple sclerosis relapse
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials
Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysis
Epilepsy in Tuberous Sclerosis: Phenotypes, Mechanisms, and Treatments
Confirmed Progression independent of Relapses activity in Multiple Sclerosis Patients under long-term Natalizumab Therapy
Stress and Multiple Sclerosis - Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progression
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study
Seasonal variation in multiple sclerosis relapse
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials
Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysis
Epilepsy in Tuberous Sclerosis: Phenotypes, Mechanisms, and Treatments
Confirmed Progression independent of Relapses activity in Multiple Sclerosis Patients under long-term Natalizumab Therapy
Stress and Multiple Sclerosis - Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progression
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression
Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study
Seasonal variation in multiple sclerosis relapse
Real-world evidence of ocrelizumab-treated relapsing multiple sclerosis cohort shows changes in progression independent of relapse activity mirroring phase 3 trials
Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysis
Epilepsy in Tuberous Sclerosis: Phenotypes, Mechanisms, and Treatments
Confirmed Progression independent of Relapses activity in Multiple Sclerosis Patients under long-term Natalizumab Therapy